IPS Therapeutique is honored to be a sponsor of the 15th Drug Discovery Strategic Summit taking place in Boston, MA on May 8-9th. As part of our participation, IPST’s Vice President, Dany Salvail, will deliver a presentation titled “The Promise and Limitation of Preclinical Models of Human Disease in Efficacy and Safety Assessment“. Attendees are encouraged to visit our exhibit table, where they can engage with Dany Salvail and Daniel Barabino to delve into discussions on our efficacy and safety models.